Apoptosis and its significance in MDS: controversies revisited
Authors:
- Yataro YoshidaYYYataro Yoshida
- Ghulam J MuftiGMGhulam J Mufti
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 23 (9) , 777-785
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- ‘Tunel’ evidence of reduced bone marrow cells apoptosis in a refractory anaemia patient treated with amifostineBritish Journal of Haematology, 1999
- Ineffective haemopoiesis and apoptosis in myelodysplastic syndromesBritish Journal of Haematology, 1998
- Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromesLeukemia, 1997
- Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor‐α concentrationBritish Journal of Haematology, 1997
- Apoptosis in normal and neoplastic hematopoiesisCritical Reviews in Oncology/Hematology, 1996
- Is apoptosis a massive process in myelodysplastic syndromes?British Journal of Haematology, 1996
- Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromesBritish Journal of Haematology, 1994
- Serum stem cell factor concentration in patients with myelodysplastic syndromesBritish Journal of Haematology, 1993
- Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony‐cluster formationStem Cells, 1991
- Apoptosis is a Common Histopathological Finding in Myelodysplasia: the Correlate of Ineffective HaematopoiesisLeukemia & Lymphoma, 1990